Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL27580187 | 0.85 | USP2 (0.53) | CA1CA2USP2LMNAKDM4E | |
| Glycerin SCHEMBL4930912 | 0.85 | USP2 (0.53) | CA1CA2USP2LMNAKDM4E | |
| Alcohol SCHEMBL10611013 | 0.84 | CA2 (0.50) | CA1CA2USP2LMNAALDH1A1 | |
| SCHEMBL125578 | 0.84 | — | — | |
| Glycerin SCHEMBL3250214 | 0.83 | LMNA (0.41) | CA1CA2USP2LMNAALDH1A1 | |
| Potassium SCHEMBL2231711 | 0.82 | — | — | |
| SCHEMBL17456437 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL833020 | 0.82 | — | — | |
| Water SCHEMBL10611016 | 0.82 | — | — | |
| SCHEMBL4731270 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2118192-B1 | AQUEOUS OLIGO- AND POLYESTER FORMULATIONS | CLARIANT FINANCE BVI LTD (VG) | 2010-05-26 | — | — | EP | claimed |
| US-20100098655-A1 | Aqueous Oligo- And Polyester Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-04-22 | — | — | US | claimed |
| US-20100098655-A1 | Aqueous Oligo- And Polyester Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100098655-A1 | Aqueous Oligo- And Polyester Formulations | PHOSPHO1, PPA1, PGLS | CA1 1605/4885CA2 1627/4885USP2 1870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.